Log inSign up
Reading a stock page
  • The tabs show the price chart, results, shareholding, events and news for this one company.
  • The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
  • Every figure names its source. "Official" means it came from NSE or BSE filings.
  • Use the star to watch the stock, or Add to portfolio to record a trade.

Prices during market hours are delayed by up to 15 minutes. Nothing here is a recommendation to buy or sell.

« Dashboard

MOREPENLAB ☆ BSE also on NSE

MOREPEN LABORATORIES LTD. · code 500288 · INE083A01026 · Pharma & Healthcare · series T · Daily price history

90.65 -1.60 (-1.73%) close on 19 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
43

ISA Signal Score: Weak

Caution: avoid adding, review holdings. Based on prices to 2026-11-19. Confidence 80%.

Trend60
Momentum40
52-week range30
Volume37
Risk32

Working for it

  • Price is above its 200-day average (long-term uptrend)
  • 50-day average is above the 200-day average
  • 50-day average is rising

Working against it

  • Price is below its 20-day average
  • Price is below its 50-day average
  • 38% below its 52-week high

Red flags

  • Very volatile: it moves about 7.1% on a typical day

Measured reference levels (not forecasts): 20-day low 90.50, 52-week high 146.80, typical daily move 6.46, two typical moves below price 77.73.

A rule-based reading of price, volume and filed numbers. It is information, not investment advice, and it can be wrong. Do your own research.

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityNot knownNeeds the yearly results. They load from NSE on their own for NSE stocks.
GrowthNot knownNeeds the yearly results.
ValuationNot knownNeeds EPS from the yearly results.
MomentumStrongAbove its 200-day average, beat NIFTY 50 by 101.2 points
RiskHighSwings 62% a year, fell up to 38% from a peak, beta 1.01

Smart Investor Tips: MOREPENLAB

Balanced / Watch for Key Level Confirmation

Actionable Insights & Positives

  • Pullback within a long-term uptrend: holding above the 200-day average (Rs 68.72) while digesting gains below the 50-day average (Rs 116.40).
  • Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.

Risk Checks & Things to Verify

  • Deep drawdown (-39.9% from 52-week high). Verify earnings trend and balance-sheet debt before treating a low price as a bargain.
  • High 30-day annualized volatility (60%). Keep initial position sizes smaller and use wider stop-review levels.

BSE Authentic Bhavcopy & Cross-Exchange Check No API Key

Runs authentic BSE price & volume verification (latest BSE Bhavcopy snapshot, split-adjusted 52W High/Low, 20/50/200 DMA alignment, and 20-day volume trend, plus cross-listed NSE MCP check when shared by ISIN).

Algorithmic Buy / Sell Prediction & Optimal Entry PriceHOLD / ACCUMULATE ON SUPPORT (Score 46/100)

Consolidating. If buying, accumulate only on dips into support at Rs 88.15 – Rs 90.65 (Ideal ~Rs 89.40). Review if price closes below Rs 61.49; upside resistance near Rs 139.64.

Optimal Buy ZoneTranche 1 (50%)Tranche 2 (50%)Stop-Loss / ReviewTarget 1 (Swing)Target 2 (Breakout)Risk : Reward
Rs 88.15 – Rs 90.65
Ideal ~Rs 89.40
Rs 90.65 Rs 88.15 Rs 61.49
ATR 7.1%
Rs 139.64 Rs 173.13 1 : 1.8
RSI 24 · Vol 0.77x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 1M change -25.6% · high 132.70 · low 88.15 · max drawdown -31.7%

Live Candlestick & TradingView Chart (MOREPENLAB)

MARKET CLOSED - EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures

P/E-price / earnings
P/B-price / book value
EPS-earnings per share
Dividend yield-from saved dividend events
Debt to equity-borrowings / equity
Sales growth-yearly, needs 2+ years
Profit growth-yearly, needs 2+ years
Operating margin-EBITDA / sales

Yearly results have not loaded yet. They are read from the official NSE results filings on their own; open this page again in a minute.

About MOREPEN LABORATORIES

No company description saved yet. Use Profile below to read about this company.

Listed on BSE NSE

Market capNot available
First listed24 Nov 1999BSE not available · NSE 24 Nov 1999
Face valueRs 2
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed

NSE: listing date, face value

Profile completeness2 of 8Missing: description, industry, share count, book value, ROE, ROCE

Not checked yet.

Profile, History and Financial records open a web search for this company in a new tab.

Shareholding

Promoters and group 35.65% 0.00 pp, public 64.35%, as on 30 Sep 2026. Holder names and history

Day range90.00 to 92.85Open 92.80
52-week high150.80 -39.9% from high (07 Oct 2026)
52-week low33.44 +171.1% from low (30 Mar 2026)
Volume1.42 L 0.3x the 20-day average
RSI (14)36 neutral
Volatility (30d)60.3%annualised
33.44
150.80

Returns

1W-4.6%
1M-25.6%
3M-6.0%
6M+110.6%
1Y+99.1%
YTD+120.7%
3Y a year+32.3%
5Y a year+13.7%

Against the NIFTY 50

PeriodMOREPENLABNIFTY 50Difference
1M-25.6%+11.5% -37.1 pts
3M-6.0%+5.3% -11.2 pts
6M+110.6%+7.9% +102.8 pts
1Y+99.1%-2.1% +101.2 pts

Risk over the past year

Volatility62%high
Deepest fall-38.4%from a peak
Beta1.01moves with the index
Best day+20.0%04 Aug 2026
Worst day-8.4%15 Sep 2026
Up days45%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 246 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

Quarterly Results (Last 8 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales / Revenue 403466425412484485570746
Sales QoQ % +5.1%+15.6%-8.8%-3.1%+17.5%+0.2%+17.5%+30.9%
Operating Profit 31.642.025.031.045.025.083.0123
Operating Margin (OPM %) 7.8%9.0%5.9%7.5%9.3%5.2%14.6%16.5%
Net Profit (PAT) 22.720.011.041.028.016.056.089.0
Profit QoQ % -28.9%-11.9%-45.0%+272.7%-31.7%-42.9%+250.0%+58.9%
Profit YoY % -35.5%-49.9%-68.6%+28.4%+23.4%-20.0%+409.1%+117.1%
Net Margin % 5.6%4.3%2.6%10.0%5.8%3.3%9.8%11.9%

Financials

Yearly results have not loaded yet.

They are read from the official NSE results filings (XBRL) on their own when this page opens: the newest year first, then up to 5 years over the next visits. If NSE cannot be reached from your host, the line under the company facts says so.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
ALIVUSALIVUS LIFE SCIENCES LIMITED 1,449.85 +0.3% - 17,768 37.7 7.6 20.2% 20.6%
ASTRAZENASTRAZENECA PHARMA INDIA LTD. 6,120.45 +1.9% - 15,301 94.7 21.5 22.7% 12.5%
AARTIPHARMAarti Pharmalabs Limited 1,024.80 +1.3% - 9,287 42.8 5.3 12.3% 11.7%
BLUEJETBlue Jet Healthcare Limited 516.80 -0.2% - 8,964 54.7 10.6 19.4% 23.0%
CIPLACIPLA LTD. 1,416.00 -0.3% - - - - - -
ALKEMAlkem Laboratories Limited 5,145.00 -1.1% - - 26.7 - 17.0% 16.0%
DIVISLABDIVIS LABORATORIES LTD. 11,178.00 +1.0% - - - - - -
WOCKPHARMAWOCKHARDT LTD. 2,186.60 +7.9% - - - - - -
RUBICONRUBICON RESEARCH LIMITED 1,726.00 +3.9% - - - - - -
APOLLOHOSPAPOLLO HOSPITALS ENTERPRISE LT 8,744.80 -0.8% - - 64.8 - 21.1% 7.9%
RAINBOWRainbow Children's Medicare Li 1,241.45 -1.3% - - - - - -
GLANDGland Pharma Limited 3,291.05 +1.9% - - - - - -
Sector median- 48.89.118.2%

The 12 largest of 80 stocks in this sector on BSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 19 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is below its 50-day average 20-day average is below the 50-day (short-term downtrend) Price is above its 200-day average (long-term uptrend) RSI 36: neutral

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the lower half of its 1-year range and is lower than it was on 24% of days in the past year.

Support (prices below today's)

20-day low88.15-2.8%
60-day low88.15-2.8%
200-day average68.72-24.2%
52-week low33.44-63.1%

Resistance (prices above today's)

50-day average116.40+28.4%
20-day high132.70+46.4%
60-day high150.80+66.4%
52-week high150.80+66.4%

Zones buyers often watch

Lower quarter of the 1-year range 33.44 to 62.78 Historically the cheapest part of the past year.
Pullback of 10% to 20% from the high 120.64 to 135.72 A common area for dips inside an uptrend.
Around the 200-day average 66.66 to 70.78 Long-term trend line, often watched as support.

Deepest fall from a peak in the past year: -38.4%. Currently -38.2% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average105.89 Price is 14.4% below
50-day average116.40 Price is 22.1% below
200-day average68.72 Price is 31.9% above
RSI (14)36Neutral
MACD (12, 26, 9)-7.61Below its signal line (momentum fading)
Volatility (30d)60.3%High yearly swings

Support and resistance

R294.02
R192.33
Pivot91.17
S189.48
S288.32

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-19 92.80 92.85 90.00 90.65 -1.73% 141,558
2026-11-18 89.05 93.70 88.15 92.25 +1.93% 250,670
2026-11-17 92.15 94.95 90.10 90.50 -4.54% 370,626
2026-11-16 99.20 102.00 94.80 94.80 -4.96% 344,087
2026-11-13 95.00 99.75 94.00 99.75 +5.00% 609,884
2026-11-12 96.50 99.30 94.00 95.00 -1.76% 252,559
2026-11-11 103.00 103.00 95.60 96.70 -2.37% 327,090
2026-11-09 94.35 99.05 94.35 99.05 +4.98% 598,869
2026-11-06 94.30 95.80 92.00 92.00 -4.96% 1,053,445
2026-11-05 102.00 104.00 95.25 96.80 -3.44% 902,007
2026-11-04 97.55 107.75 97.55 100.25 -2.34% 757,588
2026-11-03 102.65 102.65 102.65 102.65 -5.00% 40,442
2026-11-02 108.05 108.05 108.05 108.05 -4.97% 54,119
2026-10-30 113.70 123.40 113.70 113.70 -4.97% 658,289
2026-10-29 119.65 119.65 119.65 119.65 -4.96% 80,910
2026-10-28 128.95 130.85 125.90 125.90 -4.98% 329,256
2026-10-27 129.00 132.70 127.25 132.50 +4.83% 1,336,898
2026-10-26 123.40 128.15 118.55 126.40 +2.56% 362,677
2026-10-23 115.50 123.80 112.10 123.25 +4.49% 616,532
2026-10-22 111.20 121.45 110.05 117.95 +1.86% 338,973
2026-10-21 118.05 123.40 115.80 115.80 -4.97% 290,203
2026-10-19 125.85 126.90 117.50 121.85 -1.42% 273,240

News from the last 15 days More

Shareholding pattern

Up to dateNSE listingChecks passed

Quarter ended 30 Sep 2026, filed 07 Oct 2026. Latest filing is for the expected quarter (Sep 2026). Company: MOREPEN LAB. LTD, ISIN INE083A01026.

Promoters and group
35.65%
0.00 pp vs Jun 2026
Public (all, Category B)
64.35%
0.00 pp vs Jun 2026

Foreign, domestic institution and mutual fund lines need the filing file for the period. An admin can load them under Admin > Shareholding tracker.

Ownership split

Trend

Latest quarter compared

CategoryPrevious (Jun 26)Latest (Sep 26)Change (pp)Change in sharesYear earlier (pp)What it may mean
Promoters and group35.65%35.65%0.00 pp-0.00 ppNo material change.
Public (all, Category B)64.35%64.35%0.00 pp-0.00 ppNo material change.

Change is in percentage points (latest percent minus previous percent), not a relative change. Mutual funds and insurers are part of domestic institutions and are never added to it. Only comparable quarters (1 to 6 months apart; about a year for the year-earlier column) are compared.

Insights and risk alerts

No rule was triggered by the data in the database. That is not a clean bill of health: the rules look only at reported holdings.

These alerts describe reported ownership. They are not buy or sell advice. Judge the company with its results, debt, valuation and announcements.

Who holds the shares

The exchange listing has no filing file for this stock, so holder names are not available.

Quarter by quarter

Quarter endedPromotersChangePublicChangeFiledSource
Sep 202635.65%0.00 pp64.35%0.00 pp07 Oct 2026NSE
Jun 202635.65%0.00 pp64.35%0.00 pp13 Jul 2026NSE
Mar 202635.65%0.00 pp64.35%0.00 pp10 Apr 2026NSE
Dec 202535.65%0.00 pp64.35%0.00 pp13 Jan 2026NSE
Sep 202535.65%0.00 pp64.35%0.00 pp09 Oct 2025NSE
Jun 202535.65%0.00 pp64.35%0.00 pp16 Jul 2025NSE
Mar 2025 revised35.65%0.00 pp64.35%0.00 pp11 Apr 2025NSE
Dec 2024 revised35.65%0.00 pp64.35%0.00 pp16 Jan 2025NSE
Sep 2024 revised35.65%0.00 pp64.35%0.00 pp14 Oct 2024NSE
Aug 202435.65%-2.57 pp64.35%+2.57 pp09 Aug 2024NSE
Jun 2024 revised38.22%0.00 pp61.78%0.00 pp18 Jul 2024NSE
Mar 202438.22%0.00 pp61.78%0.00 pp19 Apr 2024NSE
Dec 202338.22%0.00 pp61.78%0.00 pp16 Jan 2024NSE
Sep 202338.22%0.00 pp61.78%0.00 pp18 Oct 2023NSE
Jun 202338.22%0.00 pp61.78%0.00 pp20 Jul 2023NSE
Mar 202338.22%0.00 pp61.78%0.00 pp20 Apr 2023NSE
Dec 202238.22%0.00 pp61.78%0.00 pp21 Jan 2023NSE
Sep 202238.22%-61.78%-20 Oct 2022NSE
Sep 202238.22%+1.48 pp61.78%-1.48 pp30 Sep 2022NSE
Jun 202236.74%0.00 pp63.26%0.00 pp20 Jul 2022NSE
May 202236.74%-1.64 pp63.26%+1.64 pp02 Jun 2022NSE
Mar 202238.38%-61.62%-20 Apr 2022NSE
Mar 202238.38%+3.84 pp61.62%-3.84 pp08 Apr 2022NSE
Dec 202134.54%0.00 pp65.46%0.00 pp21 Jan 2022NSE
Shareholding details

Loading...

Events

Not checked yet

BSE events come from the BSE corporate actions file, which an admin uploads. There is no automatic BSE fetch. Nothing has been imported for this stock yet.

No events saved for this stock yet.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.

ISA shows information and signals worked out from past prices and company filings. They are not recommendations to buy, sell or hold any security, and ISA is not a SEBI-registered investment adviser or research analyst. Prices may be delayed. Check with a registered adviser before you invest.